Member Exclusive

Charity–academia partnership receives success payment for cancer epigenetics research

Cancer Research Technology (an arm of Cancer Research UK; London, UK) has received a success payment from GlaxoSmithKline (Brentford, UK) as reward for its collaborative research efforts developing molecules targeting cancer epigenetics.

Go to the profile of Stella Bennett
Oct 11, 2016
0
0

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.